abrdn Life Sciences Investors (HQL) is a publicly traded Financial Services sector company. As of May 21, 2026, HQL trades at $17.23 with a market cap of $537.31M and a P/E ratio of 0.00. HQL moved +1.41% today. Year to date, HQL is +6.90%; over the trailing twelve months it is +38.84%. Its 52-week range spans $10.55 to $18.46. Rallies surfaces HQL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Recent HQL insider activity includes Pittard Christian bought 7.92K, Saba Capital Management, L.P. sold 41.62K, Saba Capital Management, L.P. sold 6.99K, Saba Capital Management, L.P. sold 40.21K, and Saba Capital Management, L.P. sold 24.33K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
| Metric | Value |
|---|---|
| Price | $17.23 |
| Market Cap | $537.31M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.56% |
| 52-Week High | $18.46 |
| 52-Week Low | $10.55 |
| Volume | 208 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
HQL analyst coverage data. Average price target: $0.00.